|
---|
As Of | Filer | Filing¹ | For·On·As | Docs:Size | Issuer | | Filing Agent | | | | | | | | | |
---|
|
---|
9/3/21 Aadi Bioscience, Inc. 8-K:1 8/30/21 10:147K Donnelley … Solutions/FA
8/30/21 Castelein Caley 4 Director² 1:8K Aadi Bioscience, Inc. Donnelley Fin’l S… 06/FA
8/30/21 Dalal Anupam 4 Director² 2:10K Aadi Bioscience, Inc. Donnelley Fin’l S… 06/FA
8/30/21 Avoro Capital Advisors LLC 4 D,%Own,Oth² 1:11K Aadi Bioscience, Inc. Schulte Roth & Z… LLP/FA
Aghazadeh Behzad
Avoro Ventures LLC
8/30/21 Avoro Capital Advisors LLC 3 Dir.,Other² 1:8K Aadi Bioscience, Inc. Schulte Roth & Z… LLP/FA
Aghazadeh Behzad
Avoro Ventures LLC
8/30/21 Avoro Capital Advisors LLC SC 13D/A 1:80K Aadi Bioscience, Inc. Schulte Roth & Z… LLP/FA
____________ | ¹ | Filing/Form Types: | | 3 | Initial Statement of Beneficial Ownership of Securities by an Insider — Form 3 { The Filer is an Insider² of the Issuer }. | | 4 | Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 { The Filer is an Insider² of the Issuer }. | | 8-K | Current Report — Form 8-K { Item 1: Business & Operations; 2: Financial Info; 3: Securities & Trading; 4: Accountants & Accounting; 5: Governance & Management; 6: Asset-Backed Securities; 7: Disclosures; 8: Events; 9: Financials }. | | SC 13D | Statement of Acquisition of Beneficial Ownership by an “Active” Investor — Schedule 13D. | | /A | Amendment to, or Amended version of, a previous Filing of this Type. | ² | Insider: The Filer is a Director, Officer, 10% Owner and/or Other “insider” of the Issuer. |
|